Takeda: Short Bowel Syndrome trials

The registry lists 25 Short Bowel Syndrome studies with Takeda as lead sponsor. 1 are open to participants now and 16 have results posted.

Phase 3 17No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel SyndromeRecruitingNCT07319832
• A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or OlderCompletedNCT05027308Phase 3Results posted
• Study of Teduglutide in Japanese Participants With Short Bowel SyndromeCompletedNCT03663582Phase 3Results posted
• An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004CompletedNCT03596164Phase 3Results posted
• Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel SyndromeCompletedNCT03571516Phase 3Results posted
• A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302CompletedNCT03268811Phase 3Results posted
• Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral SupportCompletedNCT02980666Phase 3Results posted
• Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)CompletedNCT02954458Phase 3Results posted
• Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 StudyCompletedNCT02949362Phase 3Results posted
• Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral NutritionCompletedNCT02682381Phase 3Results posted
• Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)CompletedNCT02340819Phase 3Results posted
• A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel SyndromeCompletedNCT01952080Phase 3Results posted
• A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021CompletedNCT01560403Phase 3Results posted
• Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)CompletedNCT00930644Phase 3Results posted
• Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) SubjectsCompletedNCT00798967Phase 3Results posted
• Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)CompletedNCT00172185Phase 3Results posted
• Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel SyndromeCompletedNCT00081458Phase 3Results posted
• A Study of Teduglutide in Chinese Adults With Short Bowel SyndromeActive, not recruitingNCT06973304Phase 3
• A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)CompletedNCT05561647
• A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in CanadaCompletedNCT05371028
• Retrospective Study on Participants With Short Bowel Syndrome and Chronic Intestinal Failure That Underwent Transplantation in BrazilCompletedNCT05113082
• A Study of Teduglutide in Japanese People With Short Bowel SyndromeCompletedNCT05023382
• A Study With Teduglutide (Revestive®) in Adults With Short Bowl SyndromeCompletedNCT04883606
• A Study of Teduglutide (Revestive®) in Children, Teenagers and Adults With Short Bowel DiseaseCompletedNCT04877431
• Registry for Participants With Short Bowel SyndromeActive, not recruitingNCT01990040